2013
DOI: 10.1039/c3ob27513b
|View full text |Cite
|
Sign up to set email alerts
|

Synthetically amenable amide derivatives of tosylated-amino acids as organocatalysts for enantioselective allylation of aldehydes: computational rationale for enantioselectivity

Abstract: A phenylalanine derived chiral amide is developed that serves as an effective organocatalyst for the reaction of allyltrichlorosilane with aryl, hetero-aryl and α,β-unsaturated aldehydes to afford the desired homoallylic alcohols in good yield (up to 90%) and high enantioselectivity (up to 99%). The experimental results and DFT calculations suggest that para substituted aromatic aldehydes as substrate show higher ee in the product than their ortho/meta counterparts. The (1)H and (13)C NMR spectra study corrobo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 77 publications
0
11
0
Order By: Relevance
“…N -Boc- d / l -Phg 7 , d / l -PheOBn 9 , and N -Ts-D/ l -Ala 13 were initially prepared, respectively. 22 Dipeptide derivatives ( N -Boc-Phg-PheOBn) 10 were then derived from 7 and 9 . 13 Finally, enantiomers G1–1–G4–2 of tripeptide derivatives ( N -Ts-Ala-Phg-PheOBn) were obtained by an amidation reaction of 11 and 13 in 34–78% yields (Scheme 2).…”
Section: Resultsmentioning
confidence: 99%
“…N -Boc- d / l -Phg 7 , d / l -PheOBn 9 , and N -Ts-D/ l -Ala 13 were initially prepared, respectively. 22 Dipeptide derivatives ( N -Boc-Phg-PheOBn) 10 were then derived from 7 and 9 . 13 Finally, enantiomers G1–1–G4–2 of tripeptide derivatives ( N -Ts-Ala-Phg-PheOBn) were obtained by an amidation reaction of 11 and 13 in 34–78% yields (Scheme 2).…”
Section: Resultsmentioning
confidence: 99%
“…organocatalysts 1-5 with varied chirality (Scheme 1). 15,17 We also synthesized catalyst (S,S)-6 (Scheme 2) by replacing the tosyl part of the catalyst (S,S)-4 with Boc to ascertain the role of the tosyl group in the allylation reaction.…”
Section: Resultsmentioning
confidence: 99%
“…However, there are nagging issues, such as the extremely low reaction temperatures, moderate yield and ee, and nonrecyclability of these catalysts, which need to be addressed. Bearing in mind the value of oxazolines, overall stability of the catalyst and our previous experience with tosylated amino acids 15 as organocatalysts in the enantioselective allylation reaction of aldehydes, herein we have synthesized a series of oxazoline-based organocatalysts, 16,17 (S,S)-1 to (S,S,R)-5, featuring sulfonamide groups with varying steric features and two to three chiral centers. Chiral centers in organocatalysts featuring congurations with different permutations and combinations were prepared for their possible role in inuencing the product enantioselectivity.…”
Section: Introductionmentioning
confidence: 99%
“…As typical examples we may mention reactions catalyzed by bipyridine N-oxides (10 mol%, 83% ee) [12] and N,N'-dioxides with a chiral terpene scaffold (10 mol%, 75% ee), [13] C 2 -symmetrical bisimidazole N,N'-dioxides (10 mol%, 76% ee), [14] and C 2 -symmetrical biscarboline N,N'-dioxides (1 mol%, 97 and 98% ee). [15] Worthy of mention is also a protocol for the addition of allyltrichlorosilane using catalysis by an amino acid (15 mol%, 82% ee) [16] or by a phosphine oxide (2 mol%, 70% ee). [17] During the last couple of years we have shown that axially chiral bipyridine N,N'-dioxides with a bis(tetrahydroisoquinoline) scaffold such as 1 and 2 ( Figure 2) are highly catalytically active substances for the enantioselective allylation of aldehydes with allyltrichlorosilane providing the corresponding homoallyl alcohols with high asymmetric inductions of up to 99% ee.…”
Section: Duloxetine [(+)-(S)-n-methyl-3-(naphthalen-1-yl-a C H T U N mentioning
confidence: 99%